Dr. Jason Hamilton is currently Senior Director of Manufacturing and Development for Legend Biotech. Jason has more than 15 years of academic and industry experience in the development of cellular therapeutics. Prior to joining Legend Biotech, Jason was Technical Project Leader at Novartis, where he was a key contributor to the CMC development and global commercial filings for the first FDA-licensed CAR-T therapy (KymriahTM). Earlier in his career, Jason served as Program Head of Transplantation and Inflammation at Athersys Inc., where he led technical development of an allogeneic cell therapy product for the treatment of both Multiple Sclerosis and GvHD. Jason holds a B.S. in Neuroscience from the University of Rochester and a Ph.D. in Neuroscience from the University of Rochester School of Medicine, with postdoctoral training at University of California, Irvine.